Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q3 2016 · 10-Q
Revenue$167.60K$167.60K+41.8% vs Q3 2015 Net Income-$2.61M-$2.61MN/M vs Q3 2015 EPS Diluted-$0.02-$0.02— vs Q3 2015 Operating Income-$517,368N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$732,811— Margins · derivedOperating margin-308.7%+119.7 pt vs Q3 2015
Net margin-1556.6%−966.5 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 17, 2016 · 48 d after period end